The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

The CEOs of dozens of leading pharmaceutical companies have warned European Commission president Ursula von der Leyen of an ‘exodus’ to the Unites States as a result of Donald Trump’s tariffs.

Novo Nordisk and Sanofi were among companies threatening to hasten their exits to the U.S., as Trump promised pharma tariffs ...

European Union member states have voted to approve retaliatory tariffs on $23 billion in goods in response to U.S. President ...

China said it will take “resolute measures” to defend its trading rights, but gave no details on how it will respond to U.S.

Stocks surged to one of their biggest gains since World War II after President Donald Trump paused his tariffs against most ...

There will soon be two gene therapies available for patients with haemophilia B in the EU after the European Commission approved Pfizer's fidanacogene elaparvovec under the Durveqtix brand name.

Pfizer's Hympavzi has become the first once ... The once-weekly anti-TFPI antibody has been cleared by the European Commission for adults and adolescents aged 123 and over with severe haemophilia ...

European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower ...

Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing ...